These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

333 related items for PubMed ID: 16311244

  • 21. Current evidence on the relationship between five polymorphisms in the matrix metalloproteinases (MMP) gene and lung cancer risk: a meta-analysis.
    Hu C, Wang J, Xu Y, Li X, Chen H, Bunjhoo H, Xiong W, Xu Y, Zhao J.
    Gene; 2013 Mar 15; 517(1):65-71. PubMed ID: 23313298
    [Abstract] [Full Text] [Related]

  • 22. A functional polymorphism (-1607 1G→2G) in the matrix metalloproteinase-1 promoter is associated with development and progression of lung cancer.
    Liu L, Wu J, Wu C, Wang Y, Zhong R, Zhang X, Tan W, Nie S, Miao X, Lin D.
    Cancer; 2011 Nov 15; 117(22):5172-81. PubMed ID: 21523769
    [Abstract] [Full Text] [Related]

  • 23. A single-nucleotide polymorphism in the matrix metalloproteinase-1 promoter enhances bladder cancer susceptibility.
    Tasci AI, Tugcu V, Ozbek E, Ozbay B, Simsek A, Koksal V.
    BJU Int; 2008 Feb 15; 101(4):503-7. PubMed ID: 17986285
    [Abstract] [Full Text] [Related]

  • 24. A single nucleotide polymorphism in the matrix metalloproteinase-3 promoter enhances breast cancer susceptibility.
    Ghilardi G, Biondi ML, Caputo M, Leviti S, DeMonti M, Guagnellini E, Scorza R.
    Clin Cancer Res; 2002 Dec 15; 8(12):3820-3. PubMed ID: 12473595
    [Abstract] [Full Text] [Related]

  • 25. Matrix metalloproteinase single-nucleotide polymorphisms and haplotypes predict breast cancer progression.
    Hughes S, Agbaje O, Bowen RL, Holliday DL, Shaw JA, Duffy S, Jones JL.
    Clin Cancer Res; 2007 Nov 15; 13(22 Pt 1):6673-80. PubMed ID: 18006768
    [Abstract] [Full Text] [Related]

  • 26. Matrix metalloproteinase 1, 3 and 12 polymorphisms and esophageal adenocarcinoma risk and prognosis.
    Bradbury PA, Zhai R, Hopkins J, Kulke MH, Heist RS, Singh S, Zhou W, Ma C, Xu W, Asomaning K, Ter-Minassian M, Wang Z, Su L, Christiani DC, Liu G.
    Carcinogenesis; 2009 May 15; 30(5):793-8. PubMed ID: 19321798
    [Abstract] [Full Text] [Related]

  • 27. Polymorphisms in the promoter regions of the matrix metalloproteinases-1, -3, -7, and -9 and the risk of epithelial ovarian cancer in China.
    Li Y, Jin X, Kang S, Wang Y, Du H, Zhang J, Guo W, Wang N, Fang S.
    Gynecol Oncol; 2006 Apr 15; 101(1):92-6. PubMed ID: 16278009
    [Abstract] [Full Text] [Related]

  • 28. Polymorphisms in the hMSH2 gene and the risk of primary lung cancer.
    Jung CY, Choi JE, Park JM, Chae MH, Kang HG, Kim KM, Lee SJ, Lee WK, Kam S, Cha SI, Kim CH, Han SB, Jung TH, Jeon SH, Park JY.
    Cancer Epidemiol Biomarkers Prev; 2006 Apr 15; 15(4):762-8. PubMed ID: 16614121
    [Abstract] [Full Text] [Related]

  • 29. Matrix metalloproteinase-1, -3, and -9 gene polymorphisms and the risk of idiopathic dilated cardiomyopathy in a Chinese Han population.
    Tang LJ, Chen XF, Zhu M, Jiang JJ, Lu XB, Du YX, Wang B, Fang CF, Xue YS, Shen WF.
    Clin Biochem; 2007 Dec 15; 40(18):1427-30. PubMed ID: 18028894
    [Abstract] [Full Text] [Related]

  • 30. Clinical implications of matrix metalloproteinase-1, -3, -7, -9, -12, and plasminogen activator inhibitor-1 gene polymorphisms in colorectal cancer.
    Woo M, Park K, Nam J, Kim JC.
    J Gastroenterol Hepatol; 2007 Jul 15; 22(7):1064-70. PubMed ID: 17608852
    [Abstract] [Full Text] [Related]

  • 31. Matrix metalloproteinase polymorphisms and survival in stage I non-small cell lung cancer.
    Heist RS, Marshall AL, Liu G, Zhou W, Su L, Neuberg D, Lynch TJ, Wain J, Christiani DC.
    Clin Cancer Res; 2006 Sep 15; 12(18):5448-53. PubMed ID: 17000679
    [Abstract] [Full Text] [Related]

  • 32. Association of -1171 promoter polymorphism of matrix metalloproteinase-3 with increased risk for oral cancer.
    Vairaktaris E, Yapijakis C, Vasiliou S, Derka S, Nkenke E, Serefoglou Z, Vorris E, Vylliotis A, Ragos V, Neukam FW, Patsouris E.
    Anticancer Res; 2007 Sep 15; 27(6B):4095-100. PubMed ID: 18225577
    [Abstract] [Full Text] [Related]

  • 33. Caspase 9 promoter polymorphisms and risk of primary lung cancer.
    Park JY, Park JM, Jang JS, Choi JE, Kim KM, Cha SI, Kim CH, Kang YM, Lee WK, Kam S, Park RW, Kim IS, Lee JT, Jung TH.
    Hum Mol Genet; 2006 Jun 15; 15(12):1963-71. PubMed ID: 16687442
    [Abstract] [Full Text] [Related]

  • 34. Matrix metalloproteinase-1 and matrix metalloproteinase-3 gene promoter polymorphisms are associated with mortality in haemodialysis patients.
    Cozzolino M, Biondi ML, Galassi A, Turri O, Brancaccio D, Gallieni M.
    Nephrol Dial Transplant; 2009 Jul 15; 24(7):2207-12. PubMed ID: 19221176
    [Abstract] [Full Text] [Related]

  • 35. Genotype-phenotype association of matrix metalloproteinase-3 polymorphism and its synergistic effect with smoking on the occurrence of acute coronary syndrome.
    Liu PY, Li YH, Chan SH, Lin LJ, Wu HL, Shi GY, Chen JH.
    Am J Cardiol; 2006 Oct 15; 98(8):1012-7. PubMed ID: 17027562
    [Abstract] [Full Text] [Related]

  • 36. A haplotype constituted of four MMP-2 promoter polymorphisms (-1575G/A, -1306C/T, -790T/G and -735C/T) is associated with coronary triple-vessel disease.
    Vasků A, Goldbergová M, Izakovicová Hollá L, Sisková L, Groch L, Beránek M, Tschöplová S, Znojil V, Vácha J.
    Matrix Biol; 2004 Jan 15; 22(7):585-91. PubMed ID: 14996438
    [Abstract] [Full Text] [Related]

  • 37. A polymorphism in the APE1 gene promoter is associated with lung cancer risk.
    Lo YL, Jou YS, Hsiao CF, Chang GC, Tsai YH, Su WC, Chen KY, Chen YM, Huang MS, Hu CY, Chen CJ, Hsiung CA.
    Cancer Epidemiol Biomarkers Prev; 2009 Jan 15; 18(1):223-9. PubMed ID: 19124501
    [Abstract] [Full Text] [Related]

  • 38. Polymorphisms in the vitamin D receptor gene and risk of lung cancer.
    Dogan I, Onen HI, Yurdakul AS, Konac E, Ozturk C, Varol A, Ekmekci A.
    Med Sci Monit; 2009 Aug 15; 15(8):BR232-42. PubMed ID: 19644412
    [Abstract] [Full Text] [Related]

  • 39. Association of matrix metalloproteinase-1 and -3 promoter polymorphisms with clinical subsets of Norwegian primary sclerosing cholangitis patients.
    Wiencke K, Louka AS, Spurkland A, Vatn M, Schrumpf E, Boberg KM, IBSEN Study Group.
    J Hepatol; 2004 Aug 15; 41(2):209-14. PubMed ID: 15288468
    [Abstract] [Full Text] [Related]

  • 40. The promoter polymorphism of the matrix metalloproteinase 3 (MMP-3) gene in women with ovarian cancer.
    Szyllo K, Smolarz B, Romanowicz-Makowska H, Niewiadomski M, Kozlowska E, Kulig A.
    J Exp Clin Cancer Res; 2002 Sep 15; 21(3):357-61. PubMed ID: 12385578
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.